TITLE

About SEQUENOM

PUB. DATE
November 2003
SOURCE
Biotech Business;Nov2003, Vol. 16 Issue 11, p5
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Provides information on the genetics company SEQUENOM Inc..
ACCESSION #
11206338

 

Related Articles

  • Fetal tests spur legal battle. Check Hayden, Erika // Nature;6/28/2012, Vol. 486 Issue 7404, p454 

    The article focuses on the legal battle of the genetic tests which analyse fetal DNA from the blood of a pregnant woman. It mentions that the commercialization of the said tests might not only affect corporate profit but can also limit the access of patients to the tests. It discusses the...

  • Sequenom cashes chips. Michael, Adam // Nature Biotechnology;Jun99, Vol. 17 Issue 6, p519 

    Reports that San Diego, California-based company Sequenom Inc. has raised 37 million dollar fund in April 1999 to support the launch of its DNA analysis products. Information about these products to be launched; Increase in share price of the company.

  • Financings Roundup.  // BioWorld Today;9/13/2012, Vol. 23 Issue 178, p7 

    The article reports on the launch of a 110 million dollar private offering of convertible senior notes due in 2017 by Sequenom Inc.

  • Financings roundup.  // Medical Device Daily;5/13/2010, Vol. 14 Issue 92, p7 

    The article reports on the decision of San Diego, California-based genetic analysis solutions manufacturer Sequenom to issue and sell an aggregate of 12,435,000 shares of its common stock to specific investors.

  • Financings roundup.  // Medical Device Daily;12/6/2010, Vol. 14 Issue 235, p2 

    The article reports that underwriters of the common stock offering of Sequenom exercised their full option to purchase 2.1 million shares.

  • BIOTECH'S BIG DUSTUP. Santini, Laura // Investment Dealers' Digest;4/14/2003, Vol. 69 Issue 15, p26 

    Focuses on the market situation of biotechnology companies in the terms of investment with reference to the case of San Diego, California-based Sequenom Inc. as of April 2003. Decline in the interest of investors in genomics companies; Decrease in underwriting, mergers and acquisition...

  • Sequenom opens Eastern ops.  // Chemical Market Reporter;12/28/98, Vol. 254 Issue 26, p33 

    Reports on Sequenom Inc.'s expansion into the genomic products market in the East Coast, with the opening of its office in Boston, Massachusetts.

  • Sequenom patent and deal. Hodgson, John // Nature Biotechnology;Oct99, Vol. 17 Issue 10, p941 

    Reports that the U.S. Patent and Trademark Office in Washington D.C. has granted a patent on DNA sequencing for four branches of Sequenom Inc. Scope of the patent; Benefits of the patent to genetic analysis.

  • Sequenom Cuts 110 Jobs, Divests N.C. Operations. MEILING, BRITTANY // San Diego Business Journal;1/18/2016, Vol. 37 Issue 3, p3 

    The article reports that diagnostic manufacturer Sequenom Inc. is expecting to reduce 20 percent of its workforce or a total of 110 jobs as part of the company's efforts to reduce operating costs and consolidate its North Carolina operations in San Diego, California in 2016.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics